Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page displays a new revision label v3.5.3, replacing the previous v3.5.2. This reflects a small update to the page version without changing its visible content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. There are no visible changes to the study details or how users interact with the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, reflecting the addition of v3.4.3 and removal of v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a Revision: v3.4.2 tag. Removed the government funding lapse notice and the prior Revision: v3.4.1 tag.SummaryDifference0.4%

- Check87 days agoChange DetectedA site-wide notice regarding government funding status and NIH Clinical Center operations has been added, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.